Literature DB >> 20347695

Functional adaptation of venous smooth muscle response to vasoconstriction in proximal, distal, and varix segments of varicose veins.

Joseph D Raffetto1, Xiaoying Qiao, Katie G Beauregard, Alain F Tanbe, Abhinav Kumar, Virak Mam, Raouf A Khalil.   

Abstract

BACKGROUND: Varicose veins (VarVs) are a common disorder of venous dilation and tortuosity with unclear mechanism. The functional integrity and the ability of various regions of the VarVs to constrict is unclear. This study tested the hypothesis that the different degrees of venodilation in different VarV regions reflect segmental differences in the responsiveness to receptor-dependent vasoconstrictive stimuli and/or in the postreceptor signaling mechanisms of vasoconstriction.
METHODS: Varix segments and adjacent proximal and distal segments were obtained from patients undergoing VarV stripping. Control great saphenous vein specimens were obtained from patients undergoing lower extremity arterial bypass and coronary artery bypass grafting. Circular vein segments were equilibrated under 2 g of tension in a tissue bath, and changes in isometric constriction in response to angiotensin II (AngII, 10(-11)-10(-7) M), phenylephrine (PHE, 10(-9)-10(-4) M), and KCl (96 mM) were recorded. The amount of angiotensin type 1 receptor (AT(1)R) was measured in vein tissue homogenate.
RESULTS: AngII caused concentration-dependent constriction in control vein (max 35.3 +/- 9.6 mg/mg tissue, pED(50) 8.48 +/- 0.34). AngII caused less contraction and was less potent in proximal (max 7.9 +/- 2.5, pED(50) 6.85 +/- 0.61), distal (max 5.7 +/- 1.2, pED(50) 6.74 +/- 0.68), and varix segments of VarV (max 7.2 +/- 2.0, pED(50) 7.11 +/- 0.50), suggesting reduced AT(1)R-mediated contractile mechanisms. VarVs and control veins had similar amounts of AT(1)R. alpha-adrenergic receptor stimulation with PHE caused concentration-dependent constriction in control veins (max 73.0 +/- 13.9 mg/mg tissue, pED(50) 5.48 +/- 0.12) exceeding that of AngII. PHE produced similar constriction and was equally potent in varix and distal segments but produced less constriction and was less potent in proximal segments of VarVs (max 32.1 +/- 6.4 mg/mg tissue, pED(50) 4.89 +/- 0.13) vs control veins. Membrane depolarization by 96 mM KCl, a receptor-independent Ca(2+)-dependent response, produced significant constriction in control veins and similar contractile response in proximal, distal, and varix VarV segments, indicating tissue viability and intact Ca(2+)-dependent contraction mechanisms.
CONCLUSIONS: Compared with control veins, different regions of VarV display reduced AngII-mediated venoconstriction, which may be involved in the progressive dilation in VarVs. Postreceptor Ca(2+)-dependent contraction mechanisms remain functional in VarVs. The maintained alpha-adrenergic responses in distal and varix segments, and the reduced constriction in the upstream proximal segments, may represent a compensatory adaptation of human venous smooth muscle to facilitate venous return from the dilated varix segments of VarV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347695      PMCID: PMC2847596          DOI: 10.1016/j.jvs.2009.11.037

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  30 in total

1.  The theoretical basis of varicose vein formation.

Authors:  C J Alexander
Journal:  Med J Aust       Date:  1972-02-05       Impact factor: 7.738

2.  Where does venous reflux start?

Authors:  N Labropoulos; A D Giannoukas; K Delis; M A Mansour; S S Kang; A N Nicolaides; J Lumley; W H Baker
Journal:  J Vasc Surg       Date:  1997-11       Impact factor: 4.268

3.  Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis.

Authors:  S Schuller-Petrovic; S Siedler; T Kern; J Meinhart; K Schmidt; F Brunner
Journal:  Br J Pharmacol       Date:  1997-10       Impact factor: 8.739

4.  Sustained contraction of vascular smooth muscle: calcium influx or C-kinase activation?

Authors:  R A Khalil; C van Breemen
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

5.  Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins.

Authors:  R H Gandhi; E Irizarry; G B Nackman; V J Halpern; R J Mulcare; M D Tilson
Journal:  J Vasc Surg       Date:  1993-11       Impact factor: 4.268

6.  ASA physical status classifications: a study of consistency of ratings.

Authors:  W D Owens; J A Felts; E L Spitznagel
Journal:  Anesthesiology       Date:  1978-10       Impact factor: 7.892

7.  Endothelial mediated enhancement of noradrenaline induced vasoconstriction in normal and varicose veins.

Authors:  O Thulesius; S Said; H Shuhaiber; P Neglen; J E Gjores
Journal:  Clin Physiol       Date:  1991-03

8.  Role of calcium influx and intracellular calcium stores in angiotensin II-mediated calcium hyper-responsiveness in smooth muscle from spontaneously hypertensive rats.

Authors:  R M Touyz; E L Schiffrin
Journal:  J Hypertens       Date:  1997-12       Impact factor: 4.844

9.  Tissue inhibitor of metalloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the leg.

Authors:  J R Parra; R A Cambria; C D Hower; M S Dassow; J A Freischlag; G R Seabrook; J B Towne
Journal:  J Vasc Surg       Date:  1998-10       Impact factor: 4.268

10.  In vitro evaluation of endothelial and smooth muscle function of primary varicose veins.

Authors:  R C Lowell; P Gloviczki; V M Miller
Journal:  J Vasc Surg       Date:  1992-11       Impact factor: 4.268

View more
  3 in total

1.  Endothelium-dependent nitric oxide and hyperpolarization-mediated venous relaxation pathways in rat inferior vena cava.

Authors:  Joseph D Raffetto; Peng Yu; Ossama M Reslan; Yin Xia; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2011-12-30       Impact factor: 4.268

2.  A comprehensive characterisation of the metabolic profile of varicose veins; implications in elaborating plausible cellular pathways for disease pathogenesis.

Authors:  Muzaffar A Anwar; Kyrillos N Adesina-Georgiadis; K Spagou; P A Vorkas; J V Li; Joseph Shalhoub; Elaine Holmes; Alun H Davies
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

3.  GPR30 Promotes the Phenotypic Switching of Vascular Smooth Muscle Cells via Activating the AKT and ERK Pathways.

Authors:  Binshan Zha; Peng Qiu; Chenxin Zhang; Xinyuan Li; Zhiyong Chen
Journal:  Onco Targets Ther       Date:  2020-05-06       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.